Overview
Beacon Biosignals has raised $86 million in an oversubscribed Series B funding round, led by Innoviva and Google Ventures, among others. The company develops AI-powered biomarkers for neurological and psychiatric diseases, aiming to enhance clinical adoption and precision medicine. Total funding now exceeds $121 million.
Products
Loading...
Recent Deals
Investors: Innoviva, Google Ventures
Beacon Biosignals has raised $86 million in an oversubscribed Series B funding round, led by Innoviva and Google Ventures, among others. The company develops AI-powered biomarkers for neurological and psychiatric diseases, aiming to enhance clinical adoption and precision medicine. Total funding now exceeds $121 million.